Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.
Journal: Nature medicine
Published: November 25, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 05, 2025
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.
Journal: Cancer discovery
Published: January 19, 2024
Myeloid-targeting immunotherapies overcome inhibitory barriers in immune-evasive neuroblastoma.
Journal: The Journal of experimental medicine
Published: August 10, 2023
ALK upregulates POSTN and WNT signaling to drive neuroblastoma.
Journal: Cell reports
Published: August 07, 2023
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.
Journal: Neoplasia (New York, N.Y.)
Published: February 06, 2021
124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: February 17, 2020
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface.
Journal: Cancer research
Published: April 05, 2019
Single-Cell Transcriptomics in Medulloblastoma Reveals Tumor-Initiating Progenitors and Oncogenic Cascades during Tumorigenesis and Relapse.
Journal: Cancer cell
Published: November 12, 2018
Last Updated: 09/26/2026